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additional risk to already critically ill patients of UGIB and markedly
worsens their prognosis. However, little data are known about the pre-
diction of MI in patients with acute UGIB.
The aim of the work was to study the predictive risk factors for
acute myocardial infarction in patients with acute upper gastrointesti-
nal bleeding.
Subjects and methods: One hundred and ﬁve patients with UGIB (67
males and 38 females) with mean age of 52.9 ± 9.3 years were enrolled
in the study. Patients were excluded from the study if there was one or
more of the following: age younger than 35 years, initial systolic blood
pressure > 100 mmHg, initial hemoglobinP 12 gm/dl, history of pre-
vious ischemic heart disease, or contraindication for upper GIT
endoscopy.
All patients were submitted to full history taken and clinical exam-
ination, emergency upper gastrointestinal endoscopy, 12-leads electro-
cardiography (ECG), CK, CK-MB, Troponin I, complete blood
picture, liver and kidney function tests, bleeding proﬁle, arterial blood
gases and electrolytes, lipid proﬁle, fasting and postprandial blood glu-
cose level, abdominal ultrasonography, and echocardiographic
assessment.
According to the presence of myocardial injury, patients were
divided into two groups: Group I; included 66 patients without myo-
cardial injur. Group II: included 39 patients with myocardial injury.
Results: Population characteristics were comparable in all groups. In
patients with myocardial injury, there were signiﬁcantly more hyper-
tensive patients, more smokers, more patients with liver cirrhosis,
and more patients with rebleeding than among those without myocar-
dial injury.
In patients with myocardial injury, mean body mass index, mean
C-reactive protein, and mean hospital were signiﬁcantly higher than
in patients without myocardial injury.
Logistic regression analysis showed that the most signiﬁcant predic-
tors for myocardial injury in descending order were: hypertension
(score = 14.48, odd ratio = 7.057, p< 0.00001), cigarette smoking
(score = 10.425, odd ratio = 5.425, p< 0.0001), liver cirrhosis
(score = 7.845, odd ratio = 4.972, p = 0.0017), body mass
index > 25 kg/m2 (score = 7.132, odd ratio = 4.214,p= 0.0073),
and C-reactive protein level > 5 mg/dl (score = 6.321, odd
ratio = 3.986, p= 0.0159).
Conclusion: Among patients with UGIB, patients with myocardial
injury had signiﬁcantly more incidence of hypertension, smoking, liver
cirrhosis, and rebleeding than those without myocardial injury. Mean
body mass index, mean C-reactive protein level, and mean hospital
stay were signiﬁcantly higher in patients with myocardial injury.
The most signiﬁcant predictors for myocardial injury in patients
with UGIB in descending order were hypertension, cigarette smoking,
liver cirrhosis, body mass index > 25 kg/m2, and C-reactive protein
level > 5 mg/dl.
See Tables 1 and 2.
http://dx.doi.org/10.1016/j.ehj.2013.12.053
Preoperative anaemia is a risk factor for mortality and morbidity fol-
lowing aortic valve surgery
Elsayed Elmistekawy, Fraser Rubens, Chris Hudson, Bernard
Mcdonald, Marc Ruel, Khanh Lam, Thierry G. Mesana, Munir
Boodhwani.
Objectives: The impact of anaemia on patients undergoing aortic valve
surgery has not been well studied. We sought to evaluate the eﬀect of
anaemia on early outcomes following aortic valve replacement (AVR).
Methods: All patients undergoing non-emergent aortic valve surgery
(n ¼ 2698) with or without other concomitant procedures between
1997 and 2010 were included. Preoperative anaemia was deﬁned as
per World Health Organization guidelines as haemoglobin (Hb)
<130 g/l in men and Hb <120 g/l in women. Multivariable analyses
were used to determine the association between preoperative anaemia
and postoperative outcomes.
Results: The prevalence of preoperative anaemia was 32.2%. Patients
with anaemia were older (71 ± 12 vs 66 ± 13 years, P< 0.001), more
likely to have urgent surgery, recent MI, higher creatinine level and
impaired preoperative left ventricular function. Overall unadjusted
mortality was 2.8% in non-anaemic patients vs 8% in anaemic
patients. Anaemic patients were more likely to require renal replace-
ment therapy (11% vs 3%, P< 0.0001) and prolonged ventilation
(24% vs 10%, P< 0.0001). Following multivariable adjustment, lower
preoperative Hb was an independent predictor of mortality (odds ratio
Table 1
Comparison between two groups.
Group I ðn ¼ 66Þ Group II ðn ¼ 39Þ p
Age (ys) 52:8 9:2 52:9 8:2 >0.05
Sex Male 41 (62.1%) 26 (66.7%) >0.05
Female 25 (37.9 %) 13 (33.3%)
Diabetes 21 (31.8%) 11 (16.6%) >0.05
Hybertension 14 (21.2%) 26 (66.7 %) <0.00001
Smoking 20 (30.3%) 27 (69.2%) < 0.00l
NSAlDs use 20 (30.3%) 9 (23.1%) >0.05
Otteriode or terlipressine use 16 (24.2 %) 16(41%) >0.05
Body mats index (kg/m2) 22:9 4:2 28:8 4:5 <0.00001
Variceal bleeding 39 (59.l %) 28 (71.8 %) >0.05
Hemoglobin (gm/dL) 7:7 2:1 8:1 1:8 > 0.05
Leukocytic count (103/mm3) 7:9 2:2 7:9 2:3 >0.05
Plateler count (103/mm3) 221 104:8 210:1 79 >0.05
Urea (mg/dl) 47:7 3l:1 49:1 27:5 >0.005
creatinine (mg/dl) 1:12 0:62 1:2 0:71 >0.005
Total proteins (gm/dl) 6:9 0:6 6:8 0:6 >005
Serum albumin (gm/dl) 3:2 0:82 3 0:83 > 0.05
ALT (SGPT) (mg/dl) 39:7 18:5 37:7 17:3 >0.05
ALT (SGOT) (mg/dl) 49:5 21:2 44:2 22:3 >0.05
LDL (mg/dl) 115:9 25:4 121:7 24:8 >0.05
HDL (mg/dl) 43:5 7:6 44:4 8:2 >0.05
Triglycerides (mg/dl) 145:1 31:9 158 35:4 >0.05
C-reactive protein (mg/dl) 2:1 1:4 6:4 3:9 >0.00001
Total CK (U/L) 217:1 123 427:4 146:6 >0.00001
CKMB (ng/ml) 1:97 0:8 4:7 1:9 >0.00001
Troponin (ng/ml) 0:01 0:001 0:4 0:008 >0.00001
Liver cirrhosis 35 (53%) 31 (79.5%) 0.0067
LAD (mm) 28:7 10:5 31:2 7:3 >0.05
LVEDD (mm) 44:9 15:1 46:3 9:1 >0.05
LVESD (mm) 27:4 10 30:8 9:5 >0.05
EF (%) 62:4 18:5 58:7 12:4 >0.05
FS (%) 33:1 11:2 30:2 9:8 >0.05
Hospital stay (days) 4:3 1:5 8:5 3:5 <0.00001
Blood transfusions (units) 2:1 1:3 2:4 1:8 >0.05
Rebelleding 1 (1.5 %) 5 (12.8%) 0.016
Table 2
Predictors of myocardial injury.
Variable Score Odd ratio p
Hypertension 14.48 7.057 <0.00001
Smoking 10.425 5.425 <0.0001
Liver cirrhosis 7.845 4.972 0.0017
Body mass index > 25 kg/m2 7.132 4.214 0.0073
C-reactive protein level > 5 mg/dL 6.321 3.956 0.0159
Octereotide or terlipressin use 3.259 2.448 >0.05
NSAlDs use 2.865 1.986 >0.05
Age > 50 years 1.131 0.448 >0.05
Mile sex 0.965 0.321 >0.05
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1.19%, 95% CI: 1.04–1.34, P= 0.007) and composite morbidity(odds
ratio 1.36%, 95% CI: 1.05–1.77, P= 0.02) after AVR. Mortality and
composite morbidity were sign ﬁcantly higher with lower levels of pre-
operative Hb.
Conclusions: Preoperative anaemia is a common ﬁnding in patients
undergoing aortic valve surgery and is an important and potentially
modiﬁable risk factor for postoperative morbidity and mortality.
http://dx.doi.org/10.1016/j.ehj.2013.12.054
Procedure related incidence of atrial ﬁbrillation after coronary artery
bypass grafting during the early postoperative period
A. El Banna, A. Ghaly, N. Farag, A. Ansary, E. Sarawe, T. El Banna
Dar Al Fouad Hospital, Cardiac Surgery, Cardiology and ICU
Departments, Egypt.
Atrial ﬁbrillation (AF), show to be a common postoperative com-
plication, observed after coronary artery bypass grafting (CABG) Dur-
ing the ﬁrst 7 postoperative days in 7–40% of patients. Some studies
conclude that oﬀ-pump coronary artery bypass (OPCABG) may
decrease the incidence of AF, whereas the combination of CABG with
heart valve replacement may result in more frequent postoperative
atrial ﬁbrillation. The aim of our study was to compare the early post-
operative AF incidence rate during ICU stay in three groups of
patients: after CABG, OPCABG, and CABG combined with valve
replacement.
Material and methods: During the period from January 2009 till Janu-
ary 2012. Clinical proﬁle of 650 patients were included in a prospective
study , factors having potential inﬂuence on postoperative AF did not
show any signiﬁcant diﬀerences between the groups. The presence of
arrhythmia history was the reason of excluding 42 patients from the
statistical analysis. 525 cases after conventional CABG, 96 after
OPCABG, and 29 after CABG combined with valve surgery were
analyzed.
Results: Atrial ﬁbrillation occurred during the postoperative ICU stay
in 9.8% of patients after CABG, in 10.2% after OPCABG, and in 21%
after CABG combined with valve replacement. There was no signiﬁ-
cant diﬀerence between CABG and OPCABG groups (P ¼ 0:965).
We observed a statistically signiﬁcant increase of the early postopera-
tive atrial ﬁbrillation incidence rate in patients after CABG combined
with valve replacement, when compared with both CABG+ OP-
CABG groups (P ¼ 0:005).
Conclusions: (1) Atrial ﬁbrillation is a common postoperative compli-
cation after myocardial revascularization procedures which prolong
ICU stay. (2) The study did not show that the incidence of postoper-
ative AF is inﬂuenced by the technique of coronary artery bypass
grafting: with or without CPB. (3) The prevalence of postoperative
AF increase when CABG is combined with valve replacement.
http://dx.doi.org/10.1016/j.ehj.2013.12.055
Regression of severe tricuspid regurgitation after mitral balloon valvot-
omy for severe mitral stenosis
Mohamed Eid Fawzy.
Background: Signiﬁcant tricuspid regurgitation (TR) is occasionally
associated with severe mitral stenosis and has an adverse impact on
morbidity and mortality in patients undergoing mitral valve surgery.
However, the eﬀect of successful mitral balloon valvotomy (MBV)
on signiﬁcant TR is not fully elucidated. The aim of this study was
to investigate TR after MBV in patients with severe mitral stenosis.
Methods: We analyzed the data of 53 patients with signiﬁcant TR
(gradeP2, on a 1 to 3 scale) from the mitral balloon valvotomy data-
base at our hospital. Patients were evaluated by Doppler echocardiog-
raphy before valvotomy and at follow-up 1 to 13 years after MBV.
Patients were divided into group A (27 patients), in whom TR
regressed by P1 scale, and group B (26 patients), in whom TR did
not regress.
Results: The Doppler-determined pulmonary artery systolic pressure
was initially higher and decreased at follow-up more in group A (from
70.7 ± 23.8 to 36.5 ± 8.3 mmHg; P < :0001) than in group B (from
48.7 ± 17.8 to 41.6 ± 13.1 mmHg; P=NS). Compared with patients
in group B, patients in group A were younger (25 ± 10 vs
35 ± 11 years; P < :005), had higher prevalence of functional TR
(85% vs 8%; P < :0001), and had lower incidence of atrial ﬁbrillation
(7% vs 38%; P < :005). Signiﬁcant decrease in right ventricular end-
diastolic dimension after MBV was noted in group A but not in group
B. The mitral valve area at late follow-up was larger in group A than in
group B (1.8 ± 0.3 vs 1.6 ± 0.3 cm2; P< .05).
Conclusions: Regression of signiﬁcant TR after successful MBV in
patients with severe mitral stenosis was observed in patients who had
severe pulmonary hypertension. This improvement in TR occurred
even in the presence of organic tricuspid valve disease.
http://dx.doi.org/10.1016/j.ehj.2013.12.056
Reperfusion therapy in renal dysfunction patients presenting with
STEMI: Which is better in the Tunisian context?
N. Bouchahda, M. Hassine, G. Chniti, M. Mahjoub, Z. Dridi, F.
Betbout, H. Gamra.
Background: Patients with renal insuﬃciency experience worse prog-
nosis after STEMI. Current guidelines do not clearly draw speciﬁc
strategies for renal dysfunction (RD) patients, and most clinical trials
exclude them from the study population.
Aim of the study: To compare primary PCI (PPCI) and thrombolysis
(using Strepokinase) results as well as in-hospital mortality after suc-
cessful reperfusion between patients with or without RD.
Methods: From January 1995 to October 2011, 1388 patients admitted
for STEMI were enrolled in the MIRAMI (MonastIR’s Acute Myo-
cardial Infarction) registry. Two reperfusion groups were identiﬁed:
PPCI (315 patients) and thrombolysis (379 patients). Patients who
underwent rescue PCI were excluded. Due to lacking clearance data,
we used a serum creatinine level >130 lmol/l to deﬁne RD patients.
We compared in each reperfusion group: (1) The success of revascular-
ization (TIMI III ﬂow restoring with <20% residual stenosis after
PPCI, pain relief with ST regression >50% 60 min after thrombolysis)
and (2) the in-hospital mortality rate after reperfusion success between
the RD patients (RD+) and normal renal function patients (RD).
Results: Ninety patients (13%) had RD, 50% of which underwent
PPCI, and 50% received thrombolytics. Among RD+ and RD-
groups, baseline characteristics were similar between the two reperfu-
sion groups.
In the PPCI group, although TIMI ﬂow was similar before angio-
plasty (p ¼ 0:82), TIMI III restoring was signiﬁcantly lower in the
RD+ group (78.6% vs 91.8%, p ¼ 0:013). Suboptimal result was also
higher in the RD+ group (13.6% vs 2.7%, p < 0:001), but ST regres-
sion after TIMI III achievement was similar in the 2 groups (p ¼ 0:43)
reﬂecting probably no microvascular damage.
In the thrombolysis group, successful reperfusion was also signiﬁ-
cantly lower when RD exists (58% vs 74%, p ¼ 0:03).
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